Humana Inc. (NYSE:HUM) Shares Sold by Fifth Third Wealth Advisors LLC

Fifth Third Wealth Advisors LLC trimmed its position in shares of Humana Inc. (NYSE:HUM) by 12.0% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,293 shares of the insurance provider’s stock after selling 176 shares during the period. Fifth Third Wealth Advisors LLC’s holdings in Humana were worth $410,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in HUM. Pzena Investment Management LLC raised its stake in shares of Humana by 538.7% in the second quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock valued at $866,250,000 after acquiring an additional 1,955,375 shares in the last quarter. Marshall Wace LLP raised its stake in shares of Humana by 118.9% in the second quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock valued at $532,564,000 after acquiring an additional 774,085 shares in the last quarter. International Assets Investment Management LLC raised its stake in shares of Humana by 261,025.1% in the third quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock valued at $2,340,660,000 after acquiring an additional 738,701 shares in the last quarter. Steadfast Capital Management LP acquired a new stake in shares of Humana in the first quarter valued at $158,813,000. Finally, Baupost Group LLC MA acquired a new stake in shares of Humana in the second quarter valued at $156,933,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

HUM has been the topic of several analyst reports. TD Cowen increased their price objective on Humana from $261.00 to $268.00 and gave the company a “hold” rating in a research note on Monday, November 4th. JPMorgan Chase & Co. raised their price target on Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a research note on Wednesday, August 21st. Leerink Partners cut Humana from an “outperform” rating to a “market perform” rating and cut their price target for the company from $400.00 to $250.00 in a research note on Wednesday, October 2nd. Piper Sandler cut Humana from an “overweight” rating to a “neutral” rating and cut their price target for the company from $392.00 to $274.00 in a research note on Thursday, October 3rd. Finally, Leerink Partnrs cut Humana from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Twenty equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Humana presently has an average rating of “Hold” and an average price target of $315.86.

Humana Price Performance

HUM stock opened at $294.02 on Thursday. The firm has a 50 day moving average of $277.86 and a 200-day moving average of $331.03. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $527.18. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The company has a market cap of $35.40 billion, a price-to-earnings ratio of 26.04, a PEG ratio of 2.17 and a beta of 0.52.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The firm had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. As a group, equities analysts expect that Humana Inc. will post 15.86 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.20%. Humana’s payout ratio is currently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.